SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Farmakis Peter

(Last) (First) (Middle)
JELD-WEN HOLDING, INC.
440 S. CHURCH STREET, SUITE 400

(Street)
CHARLOTTE NC 28202

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/27/2017
3. Issuer Name and Ticker or Trading Symbol
JELD-WEN Holding, Inc. [ JELD ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & President, Australasia
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Option (Right to Buy) (1) 05/02/2024 Common Stock 3,520 $18.79 D
Common Stock Option (Right to Buy) (1) 05/02/2024 Common Stock 3,520 $14.07 D
Common Stock Option (Right to Buy) (2) 05/02/2024 Common Stock 10,560 $9.97 D
Class B-1 Stock Option (Right to Buy)(6) (1) 05/02/2024 Common Stock 13,060(4) $10.76(4) D
Class B-1 Stock Option (Right to Buy)(6) (3) 05/02/2024 Common Stock 52,240(5) $6.74(5) D
Explanation of Responses:
1. This option is fully vested.
2. This option will vest in equal installments on May 2, 2017, May 2, 2018 and May 2, 2019.
3. This option is vested with respect to 13,060 underlying shares and will vest with respect to the remaining 39,180 underlying shares in equal installments on May 2, 2017, May 2, 2018 and May 2, 2019.
4. As of the date of the reporting event, and prior to the Class B-1 Conversion (as defined below), represents Class B-1 Stock Options exercisable for an aggregate of 7,480 shares of Class B-1 Common Stock, each with an exercise price of $18.79.
5. As of the date of the reporting event, and prior to the Class B-1 Conversion, represents Class B-1 Stock Options exercisable for an aggregate of 29,920 shares of Class B-1 Common Stock, each with an exercise price of $11.77.
6. Immediately prior to the consummation of the initial public offering of the issuer's Common Stock, Class B-1 Stock Options will become exercisable for Common Stock (the "Class B-1 Conversion"). For purposes of this table, the number of options and the applicable exercise prices are presented on a post-Class B-1 Conversion basis. The footnotes above indicate the number of Class B-1 Stock Options outstanding and the applicable exercise prices with respect to shares of Class B-1 Common Stock as of the date of the reporting event.
/s/ Laura W. Doerre, Attorney-in-Fact for Peter Farmakis 01/27/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.